Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib and its combination with lonafarnib improve fat cell formation in certain genetic disorders.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

Ber‐EP4 marks cells related to the secondary hair germ in hair follicles.

A PIK3CA mutation in Schwann cells causes severe nerve damage and increased glycolysis, but early treatment can help.

Topical bexarotene 1% gel might help regrow hair in alopecia areata and is generally safe.

The Brigham Eyelash Tool for Alopecia (BELA) is a reliable way to measure eyelash loss in alopecia areata patients.

BMS-470539 reduces skin fibrosis and inflammation.

Vemurafenib causes skin side effects similar to RASopathies, requiring regular skin checks and UVA protection.

The F2 hair tonic with shallot extract is effective and stable for hair growth.

Ritlecitinib and baricitinib are similarly effective for hair regrowth in severe alopecia areata.

Baricitinib is a promising treatment for severe alopecia areata with minimal side effects.

Baricitinib effectively regrows hair in most people with severe alopecia, especially those with patchy hair loss, but hair may fall out again if treatment stops.

Bikunin is found on the cell boundaries of certain skin layers and may help regulate skin and hair functions.

Pseudofolliculitis barbae is a chronic skin condition affecting mainly African American and Hispanic individuals, caused by shaving tightly curled hair, and managed by prevention and treatment but not curable.

Baricitinib is effective and cost-efficient for treating severe alopecia areata in adults.

New hydrogel sensors can be quickly made and customized for wearable devices.

Bcl-2 affects hair growth and pigmentation by controlling cell death.

Adding Baricitinib for severe alopecia areata will have a small impact on a health plan's budget.

JAK inhibitors show promise for treating various skin disorders effectively and safely.

Meniran leaf extract pomade with 10% concentration effectively stimulates hair growth in rabbits.

Baricitinib is a promising treatment for alopecia areata.

Baricitinib treatment for severe alopecia areata shows significant improvement by 52 weeks, especially in very severe cases.

Switching to ritlecitinib improves hair regrowth and well-being in severe alopecia areata patients.

Removing MCPIP1 from myeloid cells in mice leads to hair loss and prevents skin tumors but causes pigmented spots.

Combining PEMF with PBST is more effective for hair regrowth than PBST alone.

Students showed strong interest in using meniran leaves for hair growth pomade.

A new microneedle patch significantly improves melanoma treatment by using a special material to activate cancer-fighting drugs and disrupt cancer cells.

Baricitinib is a relatively safe and effective treatment for severe alopecia areata.